Trial
NCT06191250
--SuPERIOR Trial--
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University Health Network, Toronto
Collaborators
Ontario Institute for Cancer Research
Condition
Non-Small Cell Lung Cancer (NSCLC)
Intervention
Durvalumab
Why stopped
Study Terminated Prior to trial activation, due to changes in SOC of the treatment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-29